Cookies Policy
X

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.

I accept this policy

Find out more here

Role of glycosaminoglycans in inflammation

No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
The full text of this article is not currently available.

Brill’s MyBook program is exclusively available on BrillOnline Books and Journals. Students and scholars affiliated with an institution that has purchased a Brill E-Book on the BrillOnline platform automatically have access to the MyBook option for the title(s) acquired by the Library. Brill MyBook is a print-on-demand paperback copy which is sold at a favorably uniform low price.

Access this article

+ Tax (if applicable)
Add to Favorites
You must be logged in to use this functionality

image of Inflammopharmacology

Glycosaminoglycans (GAGs) are large, polyanionic molecules expressed throughout the body, either in association with cell surfaces and extracellular matrices, or stored within intracellular compartments. The GAG heparin is synthesised by and stored exclusively in mast cells, which are strongly associated with allergy and inflammation and is co-released with histamine upon cellular degranulation. The closely related GAG heparan sulphate is expressed, as part of a proteoglycan, on cell surfaces. Most notably, heparan sulphate is associated with the surfaces of vascular endothelial cells, known to be pivotally involved in the control of inflammatory cell adhesion and extravasation. The physiological role of these molecules is not well understood but evidence suggests that they may be involved in limitation of the inflammatory response and, in particular, regulation of cell adhesion and trafficking.

Affiliations: 1: Sackler Institute of Pulmonary Pharmacology, Division of Pharmacology and Therapeutics, GKT School of Biomedical Sciences, King's College London, England

10.1163/156856001300248443
/content/journals/10.1163/156856001300248443
dcterms_title,pub_keyword,dcterms_description,pub_author
6
3
Loading
Loading

Full text loading...

/content/journals/10.1163/156856001300248443
Loading

Data & Media loading...

http://brill.metastore.ingenta.com/content/journals/10.1163/156856001300248443
Loading

Article metrics loading...

/content/journals/10.1163/156856001300248443
2001-05-31
2016-12-04

Sign-in

Can't access your account?
  • Tools

  • Add to Favorites
  • Printable version
  • Email this page
  • Subscribe to ToC alert
  • Get permissions
  • Recommend to your library

    You must fill out fields marked with: *

    Librarian details
    Your details
    Why are you recommending this title?
    Select reason:
     
    Inflammopharmacology — Recommend this title to your library
  • Export citations
  • Key

  • Full access
  • Open Access
  • Partial/No accessInformation